{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T14:29:33Z","timestamp":1748269773404},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.pdpdt.2024.104072","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T02:05:29Z","timestamp":1711764329000},"page":"104072","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Choroidal Thickness and brolucizumab intravitreal injection: Cause or effect of intraocular inflammation?"],"prefix":"10.1016","volume":"47","author":[{"given":"Gilda","family":"Cennamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Malvone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pdpdt.2024.104072_bib0001","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/IAE.0000000000003862","article-title":"Intraocular inflammation incidence after intravitreal brolucizumab injection exudative age-related macular degeneration","volume":"43","author":"Pakravan","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104072_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000337152","article-title":"Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors","volume":"227","author":"Chong","year":"2012","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.pdpdt.2024.104072_bib0003","first-page":"670","article-title":"Side Effects of Brolucizumab","volume":"16","author":"Motevasseli","year":"2021","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.pdpdt.2024.104072_bib0004","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related maculare degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophtalmology"},{"key":"10.1016\/j.pdpdt.2024.104072_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ophtha.2020.06.028","article-title":"Hawk and HARRIER: ninety-six-week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration","volume":"128","author":"Dugel","year":"2021","journal-title":"Ophtalmology"},{"key":"10.1016\/j.pdpdt.2024.104072_bib0006","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajo.2014.06.019","article-title":"Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes","volume":"158","author":"Goldberg","year":"2014","journal-title":"Am. J. Ophtalmol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002400111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002400111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T16:48:20Z","timestamp":1719852500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157210002400111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":6,"alternative-id":["S157210002400111X"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104072","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choroidal Thickness and brolucizumab intravitreal injection: Cause or effect of intraocular inflammation?","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104072"}}